Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Nuclear Cardiology
Published in: Journal of Nuclear Cardiology 3/2018

01-06-2018 | Editorial

Could 82Rb-PET be the next best thing in evaluation of myocardial salvage?

Authors: Efstathia Andrikopoulou, MD, Steven G. Lloyd, MD, PhD

Published in: Journal of Nuclear Cardiology | Issue 3/2018

Login to get access

Excerpt

Success of revascularization of an infarct-related artery (IRA) currently relies on a combination of clinical, laboratory, electrocardiographic, and echocardiographic markers. Despite integrated use of these myriad tests, they do not always accurately represent the actual amount of salvaged myocardium. In an effort to more objectively quantify success of reperfusion strategies, imaging of both the initial myocardial area at risk (AAR) and the final infarct size (FIS) are now being explored as surrogates for successful reperfusion. In addition, the difference between AAR and FIS gives the amount of salvaged myocardium. The ratio of the difference over initial AAR represents the myocardial salvage index (MSI), which has the advantage of allowing for comparisons among infarcts of variable size. …
Literature
1.
Bøtker HE, Kaltoft AK, Pedersen SF, Kim WY. Measuring myocardial salvage. Cardiovasc Res. 2012;94(2):266–75.CrossRefPubMed
2.
Ndrepepa G, Mehilli J, Schwaiger M, Schuhlen H, Nekolla S, Martinoff S, et al. Prognostic value of myocardial salvage achieved by reperfusion therapy in patients with acute myocardial infarction. J Nucl Med. 2004;45:725–9.PubMed
3.
Miller TD, Hodge DO, Sutton JM, Grines CL, O’Keefe JH, DeWood MA, et al. Usefulness of technetium-99m sestamibi infarct size in predicting posthospital mortality following acute myocardial infarction. Am J Cardiol. 1998;81:1491–3.CrossRefPubMed
4.
Ghotbi AA, Kjaer A, Nepper-Christensen L, Ahtarovski KA, Lønborg JT, Vejlstrup N et al Subacute cardiac rubidium-82 positron emission tomography (82Rb-PET) to assess myocardial area at risk, final infarct size, and myocardial salvage after STEMI. J Nucl Cardiol. 2016; [Epub ahead of print].
5.
Stork A, Lund GK, Muellerleile K, et al. Characterization of the peri infarction zone using T2-weighted MRI and delayed-enhancement MRI in patients with acute myocardial infarction. Eur Radiol. 2006;16:2350–7.CrossRefPubMed
6.
Friedrich MG, Abdel-Aty H, Taylor A, Schulz-Menger J, Messroghli D, Dietz R. The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance. J Am Coll Cardiol. 2008;51:1581–7.CrossRefPubMed
7.
Carlsson M, Ubachs JF, Hedström E, Heiberg E, Jovinge S, Arheden H. Myocardium at risk after acute infarction in humans on cardiac magnetic resonance: Quantitative assessment during follow-up and validation with single-photon emission computed tomography. JACC Cardiovasc Imaging. 2009;2(5):569–76.CrossRefPubMed
8.
Eitel I, Desch S, Fuernau G, Hildebrand L, Gutberlet M, Schuler G, et al. Prognostic significance and determinants of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction. J Am Coll Cardiol. 2010;55:2470–9.CrossRefPubMed
9.
Larose E, Rodes-Cabau J, Pibarot P, Rinfret S, Proulx G, Nguyen CM, et al. Predicting late myocardial recovery and outcomes in the early hours of ST-segment elevation myocardial infarction traditional measures compared with microvascular obstruction, salvaged myocardium, and necrosis characteristics by cardiovascular magnetic resonance. J Am Coll Cardiol. 2010;55:2459–69.CrossRefPubMed
10.
Ibrahim T, Hackl T, Nekolla SG, Breuer M, Feldmair M, Schomig A, et al. Acute myocardial infarction: Serial cardiac MR imaging shows a decrease in delayed enhancement of the myocardium during the 1st week after reperfusion. Radiology. 2010;254:88–97.CrossRefPubMed
11.
O’Regan DP, Ahmed R, Karunanithy N, Neuwirth C, Tan Y, Durighel G, et al. Reperfusion hemorrhage following acute myocardial infarction: Assessment with T2* mapping and effect on measuring the area at risk. Radiology. 2009;250:916–22.CrossRefPubMed
12.
Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100:1992–2002.CrossRefPubMed
13.
Ortiz-Perez JT, Meyers SN, Lee DC, Kansal P, Klocke FJ, Holly TA, et al. Angiographic estimates of myocardium at risk during acute myocardial infarction: Validation study using cardiac magnetic resonance imaging. Eur Heart J. 2007;28:1750–8.CrossRefPubMed
14.
Hadamitzky M, Langhans B, Hausleiter J, Sonne C, Kastrati A, Martinoff S, et al. The assessment of area at risk and myocardial salvage after coronary revascularization in acutemyocardial infarction: comparison between CMR and SPECT. JACC Cardiovasc Imaging. 2013;6(3):358–69.CrossRefPubMed
15.
Langhans B, Nadjiri J, Jähnichen C, Kastrati A, Martinoff S, Hadamitzky M. Reproducibility of area at risk assessment in acute myocardial infarction by T1- and T2-mapping sequences in cardiac magnetic resonance imaging in comparison to Tc99m-sestamibi SPECT. Int J Cardiovasc Imaging. 2014;30(7):1357–63.CrossRefPubMed
16.
Bulluck H, White SK, Rosmini S, Bhuva A, Treibel TA, Fontana M, et al. T1 mapping and T2 mapping at 3T for quantifying the area-at-risk in reperfused STEMI patients. J Cardiovasc Magn Reson. 2015;12(17):73.CrossRef
17.
Ugander M, Bagi PS, Oki AJ, Chen B, Hsu LY, Aletras AH, et al. Myocardial edema as detected by pre-contrast T1 and T2 CMR delineates area at risk associated with acute myocardial infarction. JACC Cardiovasc Imaging. 2012;5(6):596–603.CrossRefPubMedPubMedCentral
18.
Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim R. Visualization of presence, location, and transmural extent of healed Q-wave and non-Q wave myocardial infarction. Lancet. 2001;357:21–8.CrossRefPubMed
19.
Wagner A, Mahrholdt H, Holly TA, Elliott MD, Regenfus M, Parker M, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial defects: An imaging study. Lancet. 2003;361:374–9.CrossRefPubMed
20.
Wright J, Adriaenssens T, Dymarkowski S, Desmet W, Bogaert J. Quantification of myocardial area at risk with T2-weighted CMR: Comparison with contrast-enhanced CMR and coronary angiography. JACC Cardiovasc Imaging. 2009;2(7):825–31.CrossRefPubMed
21.
Bulluck H, White SK, Fröhlich GM, Casson SG, O’Meara C, Newton A. Quantifying the area at risk in reperfused st-segment-elevation myocardial infarction patients using hybrid cardiac positron emission tomography-magnetic resonance imaging. Circ Cardiovasc Imaging. 2016;9(3):e003900.CrossRefPubMedPubMedCentral
22.
Nensa F, Poeppel T, Tezgah E, Heusch P, Nassenstein K, Mahabadi AA, et al. Integrated FDG PET/MR imaging for the assessment of myocardial salvage in reperfused acute myocardial infarction. Radiology. 2015;276(2):400–7.CrossRefPubMed
Metadata
Title
Could 82Rb-PET be the next best thing in evaluation of myocardial salvage?
Authors
Efstathia Andrikopoulou, MD
Steven G. Lloyd, MD, PhD
Publication date
01-06-2018
Publisher
Springer US
Published in
Journal of Nuclear Cardiology / Issue 3/2018
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-016-0733-7

Other articles of this Issue 3/2018

Journal of Nuclear Cardiology 3/2018 Go to the issue

Review of the Literature

Cardiovascular disease in the literature: A selection of recent original research papers

Editorial

Cardiac PET/MRI enters the clinical arena! Finally…

Review Article

Invasive assessment of coronary artery disease

Original Article

Summed thickening score by myocardial perfusion imaging: A risk factor of left ventricular remodeling in patients with myocardial infarction

Theme Article

Evolving, innovating, and revolutionary changes in cardiovascular imaging: We’ve only just begun!

Brief Report

SPECT myocardial ischemia in the absence of obstructive CAD: Contribution of the invasive assessment of microvascular dysfunction

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits